Dr. Jeanette Wood is an accomplished scientist with extensive experience in all aspects of drug discovery across multiple disease areas, including cancer.

Dr. Vladimir Cmiljanovic is a renowned serial biotech entrepreneur, cancer scientist, and medicinal chemist with over 15 years of experience in oncology drug development.

Dr. Natasa Cmiljanovic is the Chief Scientific Officer and Founder of Swiss Rockets, with over a decade of experience in oncology drug development as a medicinal chemist and clinical scientist.

Dr. Thomas Ladner, Board Member and Secretary of the Board, became in 2002 the youngest partner at Meyerlustenberger Lachenal, one of Switzerland's leading law firms, where he specialized in private equity and M&A. From 2000 to 2004, Thomas lectured on corporate law and contract law at the University of St. Gallen (Switzerland), from where he also holds a Ph.D.

Marco Illy is an investment banker who spent 30 years with Credit Suisse. After holding various positions including Head of the Investment Banking and Securities division of Credit Suisse in Switzerland, he was co-head of the European Investment Banking Coverage in London and in 2005, he was appointed head of Credit Suisse’s investment banking business in Germany.

Christoph Brutschin obtained his economic degrees at the University of applied sciences of Zürich and at the University of Fribourg. He held positions with PWC and maxit AG (Switzerland) before becoming a headmaster of the Basel commercial vocational training college.